Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Health-EpiGEICAM
WCRF/AICR guidelines
breast cancer
cancer prevention recommendations
compliance
health behaviours
healthy lifestyle
lifestyle recommendations
survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 Sep 2022
27 Sep 2022
Historique:
received:
09
09
2022
accepted:
23
09
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
15
10
2022
Statut:
epublish
Résumé
Breast cancer (BC) survivors are advised to follow the WCRF/AICR cancer prevention recommendations, given their high risk of developing a second tumour. We aimed to explore compliance with these recommendations in BC survivors and to identify potentially associated clinical and sociodemographic factors. A total of 420 BC survivors, aged 31-80, was recruited from 16 Spanish hospitals. Epidemiological, dietary and physical activity information was collected through questionnaires. A 7-item score to measure compliance with the recommendations was built according to the 2018 WCRF/AICR scoring criteria. Standardized prevalences and standardized prevalence ratios of moderate and high compliance across participant characteristics were estimated using multinomial and binary logistic regression models. The mean score was 3.9 (SD: 1.0) out of 7 points. Recommendations with the worst adherence were those of limiting consumption of red/processed meats (12% of compliance, 95% CI: 8.2-15.0) and high fibre intake (22% of compliance, 95% CI: 17.6-27.0), while the best compliance was observed for the consumption of fruits and vegetables (73% of compliance, 95% CI: 69.2-77.7). Overall, adherence was worse in women with university education and in those with first-degree relatives with BC. This information may be of interest to design and implement personalized preventive measures adapted to the characteristics of these patients.
Identifiants
pubmed: 36230628
pii: cancers14194705
doi: 10.3390/cancers14194705
pmc: PMC9561971
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fundación Científica Asociación Española Contra el Cancer
ID : AECC 2016
Références
Cancers (Basel). 2021 Oct 23;13(21):
pubmed: 34771493
Int J Environ Res Public Health. 2019 Apr 15;16(8):
pubmed: 30991645
Nutrients. 2020 Feb 26;12(3):
pubmed: 32110887
Fam Cancer. 2007;6(3):287-94
pubmed: 17429760
Ann Oncol. 2020 Mar;31(3):352-368
pubmed: 32067678
J Clin Epidemiol. 2007 Sep;60(9):874-82
pubmed: 17689803
Nutrients. 2019 Jul 12;11(7):
pubmed: 31336836
Breast. 2019 Apr;44:144-152
pubmed: 30780085
J Hum Nutr Diet. 2011 Apr;24(2):128-34
pubmed: 21332835
Br J Cancer. 2014 Sep 23;111(7):1454-62
pubmed: 25101568
Obes Rev. 2011 Apr;12(4):282-94
pubmed: 20880127
BMC Med. 2019 Dec 2;17(1):221
pubmed: 31787099
Br J Nutr. 2022 Mar 28;127(6):927-938
pubmed: 33988098
Support Care Cancer. 2019 Dec;27(12):4565-4574
pubmed: 30927111
Br J Nutr. 2017 Mar;117(5):737-749
pubmed: 28366183
J Cancer Surviv. 2019 Apr;13(2):257-268
pubmed: 30982113
Br J Nutr. 2021 May 28;125(10):1188-1200
pubmed: 33087189
J Gen Intern Med. 2014 Jul;29(7):1060-4
pubmed: 24452418
Clin Nutr. 2021 Apr;40(4):1537-1545
pubmed: 33743289
Nutrients. 2019 Jul 03;11(7):
pubmed: 31277273
Mayo Clin Proc. 2019 Nov;94(11):2178-2188
pubmed: 31623843
Nutr J. 2013 Feb 19;12:26
pubmed: 23421854
Gynecol Oncol. 2017 Mar;144(3):577-585
pubmed: 28057355
BMJ Open. 2018 Feb 19;8(2):e014530
pubmed: 29459359
Eur J Nutr. 2019 Oct;58(7):2875-2886
pubmed: 30284064
Am J Epidemiol. 2004 Aug 15;160(4):301-5
pubmed: 15286014
Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1153-61
pubmed: 23576689
Br J Nutr. 2019 Mar;121(5):481-495
pubmed: 30630543
J Clin Oncol. 2008 May 1;26(13):2198-204
pubmed: 18445845
Cancer Causes Control. 2016 Nov;27(11):1303-1314
pubmed: 27644127
Support Care Cancer. 2017 Aug;25(8):2581-2591
pubmed: 28303381
Brain Behav Immun. 2022 Jan;99:307-316
pubmed: 34673177
J Cancer Surviv. 2010 Jun;4(2):119-27
pubmed: 20180037
Nutr Cancer. 2021;73(9):1570-1580
pubmed: 32795218
Cancer Epidemiol Biomarkers Prev. 2020 May;29(5):889-894
pubmed: 32152215
J Ga Public Health Assoc. 2016 Fall;6(2 Suppl):210-222
pubmed: 28066830
Integr Cancer Ther. 2014 Mar;13(2):114-20
pubmed: 24105362
Nutrients. 2017 Mar 25;9(4):
pubmed: 28346353
Nutr J. 2011 Oct 25;10:118
pubmed: 22027238
Adicciones. 2022 Feb 16;34(1):61-72
pubmed: 32677700
Breast Cancer Res Treat. 2020 Aug;182(3):727-738
pubmed: 32535764
PLoS One. 2015 May 15;10(5):e0126096
pubmed: 25978407
Int J Cancer. 2016 Jan 1;138(1):237-44
pubmed: 26175188
Sci Rep. 2017 Apr 4;7(1):599
pubmed: 28377568
Cancer Treat Rev. 2012 Apr;38(2):152-63
pubmed: 21612873
Clin Pharmacol Ther. 2011 Jul;90(1):164-8
pubmed: 21633341
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
J Cancer Surviv. 2019 Jun;13(3):327-343
pubmed: 30993648
BMJ. 2018 Feb 14;360:k322
pubmed: 29444771
Front Oncol. 2019 Jan 22;9:3
pubmed: 30723698
Nutrients. 2020 Jul 13;12(7):
pubmed: 32668662